Obstetric Medicine > Volume 2, Number 1 > Pp. 17-20

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Hossain, N Articles by Paidas, M J Search for Related Content Social Bookmarking                      What's this?

Original articles

Liver dysfunction in pregnancy: an important cause of maternal and perinatal morbidity and mortality in Pakistan

N Hossain MBBS FCPS   ^*  , T Shamsi MBBS FRC(Path)   , E Kuczynski PhD   , C J Lockwood MD    and M J Paidas MD   

^* Dow University of Health Sciences, Karachi, Pakistan; Yale Women and Children's Center for Blood Disorders, Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA; National Institute of Blood Diseases, Karachi, Pakistan

Correspondence to: Nazli Hossain, Associate Professor, Dow University of Health Sciences, Karachi, Pakistan Email: nazlih1999{at}gmail.com

The objective of this study was to evaluate the maternal and perinatal outcome of women with liver dysfunction during pregnancy. The study involved a prospective observational study design and was carried out at the Dow University of Health Sciences and Civil Hospital Karachi, Pakistan. A total of 800 women, who delivered during the study period from January 2006 to September 2006, constituted the study population. Pregnant women with liver dysfunction underwent evaluation for the aetiology of their liver dysfunction, including screening for hepatitis E. Thirty-five women were identified with liver dysfunction. Fourteen (40%) presented in the second trimester and 21 (60%) presented in the third trimester. Twenty-two of the 35 women (63%) had isolated acute hepatitis E; five (14%) had HELLP (haemolysis, elevated liver enzymes and low platelet count) syndrome; two (6%) had intrahepatic cholestasis of pregnancy (IHCP), two had acute fatty liver of pregnancy (AFLP) and two women had hepatitis A. A specific diagnosis was not reached in two women who died prior to delivery. In women with hepatitis E, the mean values of bilirubin and alanine transaminase were 12 mg/dL and 675 U/L, respectively. Abnormal coagulation parameters were present in 20 (57%) of the women and in 18 of 22 (82%) with hepatitis E. Fulminant hepatic failure (FHF) was seen in four patients. Seven women (20%) underwent caesarean section, 26 (74%) delivered vaginally and two women died undelivered. There were six maternal deaths in the study population; two were due to hepatitis E, one each from HELLP and AFLP, and two remained undiagnosed. The overall perinatal mortality within the group was 43%. Hepatitis E was the most common cause of FHF and maternal death in pregnant women with liver dysfunction.

Key Words: hepatitis • hepatitis E • maternal mortality • Pakistan

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?